p38 Mitogen-Activated Protein Kinase Is Crucially Involved in Osteoclast Differentiation but Not in Cytokine Production, Phagocytosis, or Dendritic Cell Differentiation of Bone Marrow Macrophages

Endocrinology

Volumn 144, Issue 11, 2003, Pages 4999-5005

  Li, Xiaotong ^a   Udagawa, Nobuyuki ^a   Takami, Masamichi ^b   Sato, Nobuaki ^a,c   Kobayashi, Yasuhiro ^a   Takahashi, Naoyuki ^a  

^a MATSUMOTO DENTAL UNIVERSITY   (Japan)

^b SHOWA UNIVERSITY   (Japan)

^c AICHI GAKUIN UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

4 (4 FLUOROPHENYL) 2 (4 METHYLSULFINYLPHENYL) 5 (4 PYRIDYL)IMIDAZOLE; ACTIVATING TRANSCRIPTION FACTOR 2; CD40 LIGAND; CYTOKINE; GRANULOCYTE COLONY STIMULATING FACTOR; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1BETA; INTERLEUKIN 6; LIPOPOLYSACCHARIDE; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE KINASE; TRANSCRIPTION FACTOR; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CELL DIFFERENTIATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; DENDRITIC CELL; ENZYME PHOSPHORYLATION; MACROPHAGE; MALE; MOUSE; NONHUMAN; OSTEOCLAST; PHAGOCYTOSIS; PRIORITY JOURNAL;

ANIMALS; BONE MARROW CELLS; CELL DIFFERENTIATION; CYTOKINES; DENDRITIC CELLS; ENZYME INHIBITORS; IMIDAZOLES; MACROPHAGES; MALE; MICE; MITOGEN-ACTIVATED PROTEIN KINASES; OSTEOCLASTS; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PHAGOCYTOSIS; PYRIDINES; SIGNAL TRANSDUCTION;

EID: 0242552020     PISSN: 00137227     EISSN: None     Source Type: Journal    
DOI: 10.1210/en.2003-0166     Document Type: Article

References (40)

1. Suda T, Takahashi N, Udagawa N, Jimi E, Gillespie MT, Martin TJ 1999 Modulation of osteoclast differentiation and function by the new members of the tumor necrosis factor receptor and ligand families. Endocr Rev 20:345-357
2. Roodman GD 1999 Cell biology of the osteoclast. Exp Hematol 27:1229-1241
3. Teitelbaum SL 2000 Bone resorption by osteoclasts. Science 289:1504-1508
4. Chambers TJ 2000 Regulation of the differentiation and function of osteoclasts. J Pathol 192:4-13
5. Kobayashi K, Takahashi N, Jimi E, Udagawa N, Takami M, Kotake S, Nakagawa N, Kinosaki M, Yamaguchi K, Shima N, Yasuda H, Morinaga T, Higashio K, Martin TJ, Suda T 2000 Tumor necrosis factor a stimulates osteoclast differentiation by a mechanism independent of the ODF/RANKL-RANK interaction. J Exp Med 191:275-286
6. Azuma Y, Kaji K, Katogi R, Takeshita S, Kudo A 2000 Tumor necrosis factor-α induces differentiation of and bone resorption by osteoclasts. J Biol Chem 275:4858-4864
7. Lynn WA, Golenbock DT 1992 Lipopolysaccharide antagonists. Immunol Today 13:271-276
8. Ulevitch RJ, Tobias PS 1995 Receptor-dependent mechanisms of cell stimulation by bacterial endotoxin. Annu Rev Immunol 13:437-457
9. Hla T, Lee MJ, Ancellin N, Paik JH, Kluk MJ 2001 Lysophospholipids- receptor revelations. Science 294:1875-1878
10. Djaldetti M, Salman H, Bergman M, Djaldetti R, Bessler H 2002 Phagocytosis - the mighty weapon of the silent warriors. Microsc Res Tech 57:421-431
11. Heath WR, Carbone FR 2001 Cross-presentation, dendritic cells, tolerance and immunity. Annu Rev Immunol 19:47-64
12. Banchereau J, Steinman RM 1998 Dendritic cells and the control of immunity. Nature 392:245-252
13. Flores-Romo L, Bjorck P, Duvert V, van Kooten C, Saeland S, Banchereau J 1997 CD40 ligation on human cord blood CD34+ hematopoietic progenitors induces their proliferation and differentiation into functional dendritic cells. J Exp Med 185:341-349
14. + hematopoietic progenitors from human cord blood differentiate along two independent dendritic cell pathways in response to GM-CSF+TNFα. J Exp Med 184:695-706
15. + bone marrow progenitors that are expanded by c-kit-ligand and yield pure dendritic cell colonies in the presence of granulocyte/macrophage colony-stimulating factor and tumor necrosis factor α. J Exp Med 182:1111-1119
16. Bleharski JR, Niazi KR, Sieling PA, Cheng G, Modlin RL 2001 Signaling lymphocytic activation molecule is expressed on CD40 ligand-activated dendritic cells and directly augments production of inflammatory cytokines. J Immunol 167:3174-3181
17. Cobb MH, Goldsmith EJ 1995 How MAP kinases are regulated. J Biol Chem 270:14843-14846
18. Raingeaud J, Whitmarsh AJ, Barrett T, Derijard B, Davis RJ 1996 MKK3-and MKK6-regulated gene expression is mediated by the p38 mitogen-activated protein kinase signal transduction pathway. Mol Cell Biol 16:1247-1255
19. Lee JC, Laydon JT, McDonnell PC, Gallagher TF, Kumar S, Green D, McNulty D, Blumenthal MJ, Heys JR, Landvatter SW 1994 A protein kinase involved in the regulation of inflammatory cytokine biosynthesis. Nature 372:739-746
20. Yosimichi G, Nakanishi T, Nishida T, Hattori T, Takano-Yamamoto T, Takigawa M 2001 CTGF/Hcs24 induces chondrocyte differentiation through a p38 mitogen-activated protein kinase (p38MAPK), and proliferation through a p44/42 MAPK/extracellular-signal regulated kinase (ERK). Eur J Biochem 268:6058-6065
21. Bhowmick NA, Zent R, Ghiassi M, McDonnell M, Moses HL 2001 Integrin β1 signaling is necessary for transforming growth factor-β activation of p38MAPK and epithelial plasticity. J Biol Chem 276:46707-46713
22. Kumar S, Votta BJ, Rieman DJ, Badger AM, Gowen M, Lee JC 2001 IL-1-and TNF-induced bone resorption is mediated by p38 mitogen activated protein kinase. J Cell Physiol 187:294-303
23. Matsumoto M, Sudo T, Saito T, Osada H, Tsujimoto M 2000 Involvement of p38 mitogen-activated protein kinase signaling pathway in osteoclastogenesis mediated by receptor activator of NF-κB ligand (RANKL). J Biol Chem 275:31155-31161
24. Li X, Udagawa N, Itoh K, Suda K, Murase Y, Nishihara T, Suda T, Takahashi N 2002 p38 MAPK-mediated signals are required for inducing osteoclast differentiation but not for osteoclast function. Endocrinology. 143:3105-3113
25. Wong BR, Josien R, Choi Y 1999 TRANCE is a TNF family member that regulates dendritic cell and osteoclast function. J Leukoc Biol 65:715-724
26. Koga T, Nishihara T, Fujiwara T, Nisizawa T, Okahashi N, Noguchi T, Hamada S 1985 Biochemical and immunobiological properties of lipopolysaccharide (LPS) from Bacteroides gingivalis and comparison with LPS from Escherichia coli. Infect Immun 47:638-647
27. 3 in osteoclast differentiation and function. Methods Enzymol 282:223-235
28. Takahashi N, Yamana H, Yoshiki S, Roodman GD, Mundy GR, Jones SJ, Boyde A, Suda T 1988 Osteoclast-like cell formation and its regulation by osteotropic hormones in mouse bone marrow cultures. Endocrinology 122:1373-1382
29. Inaba K, Turley S, Iyoda T, Yamaide F, Shimoyama S, Reis e Sousa C, Germain RN, Mellman I, Steinman RM 2000 The formation of immunogenic major histocompatibility complex class II-peptide ligands in lysosomal compartments of dendritic cells is regulated by inflammatory stimuli. J Exp Med 191:927-936
30. Baldassare JJ, Bi Y, Bellone CJ 1999 The role of p38 mitogen-activated protein kinase in IL-1β transcription. J Immunol 162:5367-5373
31. Rawadi G, Ramez V, Lemercier B, Roman-Roman S 1998 Activation of mitogen-activated protein kinase pathways by Mycoplasma fermentans membrane lipoproteins in murine macrophages: involvement in cytokine synthesis. J Immunol 160:1330-1339
32. Lu HT, Yang DD, Wysk M, Gatti E, Mellman I, Davis RJ, Flavell RA 1999 Defective IL-12 production in mitogen-activated protein (MAP) kinase kinase 3 (Mkk3)-deficient mice. EMBO J 18:1845-1857
33. Wang X, Studzinski GP 2001 Inhibition of p38MAP kinase potentiates the JNK/SAPK pathway and AP-1 activity in monocytic but not in macrophage or granulocytic differentiation of HL60 cells. J Cell Biochem 82:68-77
34. Cuenda A, Rouse J, Doza YN, Meier R, Cohen P, Gallagher TF, Young PR, Lee JC 1995 SB 203580 is a specific inhibitor of a MAP kinase homologue which is stimulated by cellular stresses and interleukin-1. FEBS Lett 364:229-3334
35. Enslen H, Raingeaud J, Davis RJ 1998 Selective activation of p38 mitogen-activated protein (MAP) kinase isoforms by the MAP kinase kinases MKK3 and MKK6. J Biol Chem 273:1741-1748
36. Young P, McDonnell P, Dunnington D, Hand A, Laydon J, Lee J 1993 Pyridinyl imidazoles inhibit IL-1 and TNF production at the protein level. Agents Actions 39:C67-C69
37. Prichett W, Hand A, Sheilds J, Dunnington D 1995 Mechanism of action of bicyclic imidazoles defines a translational regulatory pathway for tumor necrosis factor α. J Inflamm 45:97-105
38. Bachmann MF, Wong BR, Josien R, Steinman RM, Oxenius A, Choi Y 1999 TRANCE, a tumor necrosis factor family member critical for CD40 ligand-independent T helper cell activation. J Exp Med 189:1025-1031
39. Ishida N, Hayashi K, Hoshijima M, Ogawa T, Koga S, Miyatake Y, Kumegawa M, Kimura T, Takeya T 2002 Large scale gene expression analysis of osteoclastogenesis in vitro and elucidation of NFAT2 as a key regulator. J Biol Chem 277:41147-41156
40. Takayanagi H, Kim S, Koga T, Nishina H, Isshiki M, Yoshida H, Saiura A, Isobe M, Yokochi T, Inoue J, Wagner EF, Mak TW, Kodama T, Taniguchi T 2002 Induction and activation of the transcription factor NFATc1 (NFAT2) integrate RANKL signaling in terminal differentiation of osteoclasts. Dev Cell 3:889-901